期刊文献+

奥氮平与氟哌啶醇治疗老年期痴呆患者精神行为症状的对照研究 被引量:20

在线阅读 下载PDF
导出
摘要 目的比较奥氮平与氟哌啶醇治疗老年期痴呆患者伴精神行为症状的疗效及安全性。方法将79例伴有精神行为症状的痴呆患者随机分为两组,分别使用奥氮平(40例)和氟哌啶醇(39例)治疗8周,治疗前后采用阿尔茨海默病行为病理量表(BEHAVE-AD)和简易精神状况检查量表(MMSE)评价疗效,采用药物不良反应症状量表(TESS)评价不良反应。结果奥氮平组(5mg/d)与氟哌啶醇组(3mg/d)治疗后BEHAVE-AD减分率≥30%者分别为92.5%和94.9%,总分均明显下降(P<0.01),两组差异无统计学意义;两组治疗前后MMSE评分差异无统计学意义(P>0.05)。两组不良反应发生率分别为22.5%和48.7%,差异有统计学意义(P<0.05),主要不良反应为嗜睡、锥体外系反应、便秘、食欲减退等。结论奥氮平和氟哌啶醇均可显著改善老年期痴呆患者的精神行为症状,但奥氮平较氟哌啶醇不良反应轻,安全性好,更适用于老年患者。
作者 康慧敏
出处 《中西医结合心脑血管病杂志》 2014年第3期320-322,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献3

  • 1沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
  • 2Finkel SI,Costae SJ,Cohen G,et al.Behavioral and psychological signs and symptoms of dementia;A consensus statement on current knowledge and implications for research and treatment[J].Int Psychogeriatr,1996,8:497-500.
  • 3孙新宇,高之旭,冯锋,温全球,冯少慧,盛建华,陈建,苗国栋,于欣.氟哌啶醇与利培酮治疗痴呆患者精神行为症状的随机双盲对照研究[J].中华精神科杂志,2004,37(3):156-159. 被引量:54

二级参考文献12

  • 1O'Connor DW. Epidemiology of behavioral and psychological symptoms of dementia. Int Psychogeriatr, 2000,12:41-45.
  • 2Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr, 1996,8:497-500.
  • 3Schneider L, Pollock V, Lyness S. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc, 1990, 28: 553-563.
  • 4Brian L. Managing behavioral and psychological symptoms in dementia. Br J Psychiatry, 2000, 181:463-465.
  • 5Reisberg B, Borenstein J, Salob SP, et al. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry, 1987, 48:9-15.
  • 6Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly I:a conceptual review. J Am Geriatr Soc, 1986,34: 711-721.
  • 7Petrie WM, Ban TA, Berney S, et al. Loxapine in psychogeriatrics: a placebo- and standard-controlled investigation. J Clin Psych-opharmacology, 1982, 2: 122-126.
  • 8Devanand DP, Marder K, Micheals KS, et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry, 1998, 155: 1512-1520.
  • 9Davidson M, Weiser M, Soares K. Novel antipsychotics in the treatment of psychosis and aggression associated with dementia: a meta-analysis of randomized controlled clinical trail. Int Psychogeriatr, 2000,12:271-277.
  • 10DeDeyn PP, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology, 1999,53:946-955.

共引文献306

同被引文献131

引证文献20

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部